Deeper remission provides better outcomes for patients with ileal Crohn’s disease, according to a new study that found histologic but not mucosal activity was a significant predictor of clinical relapse over time.
Although histologic healing is the ultimate aim of treatment, researchers acknowledged that this goal might be a more ideal than practical strategy, given the current options for disease control.
“I don’t think we can target histological healing. We have enough